MedTrace Logo

Hematological Markers in Idiopathic Carpal Tunnel Syndrome

NCT06952647 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 70

Last updated 2026-03-25

No results posted yet for this study

Summary

Carpal Tunnel Syndrome (CTS) cases are still classified as idiopathic. The rationale of this research is to investigate the role of chronic inflammation and vitamin B12 deficiency in the onset and severity of idiopathic CTS. This case-control study aims to evaluate inflammatory hematological markers and vitamin B12 levels in patients with idiopathic CTS compared to healthy controls, and to analyze their correlation with clinical and electrophysiological severity of the disease

Conditions

  • Carpal Tunnel Syndrome (CTS)
  • Biomarkers / Blood

Sponsors & Collaborators

  • Ankara Training and Research Hospital

    lead OTHER

Principal Investigators

  • Nadide Koca, M.D. · University of Health Sciences, Ankara Training and Research Hospital, TURKEY

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-04-01
Primary Completion
2026-01-15
Completion
2026-01-20

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06952647 on ClinicalTrials.gov